Edwards Lifesciences Corp
(NYSE:EW)
$
75.38
0.57 (0.76%)
Market Cap: 44.12 Bil
Enterprise Value: 40.45 Bil
PE Ratio: 10.80
PB Ratio: 4.62
GF Score: 84/100 Edwards Lifesciences Corp at Wells Fargo Healthcare Conference Transcript
Sep 08, 2022 / 01:45PM GMT
Release Date Price:
$95.52
(+3.85%)
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
All right. Good morning, everyone. I'm Larry Biegelsen, in the medical device analyst at Wells Fargo. It's my pleasure to host this session with Edwards Lifesciences.
With us, we have Scott Ullem, the CFO; and Mark Wilterding, Head of Investor Relations. In terms of format, it's going to be a fireside chat. If anyone has a question they want me to ask or they want to ask, just raise your hand and we'll call on you. So Scott, thanks so much for being here.
Scott B. Ullem
Edwards Lifesciences Corporation - Corporate VP & CFO
It's our pleasure. Thanks for having us.
Questions & Answers
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
So Scott, we're starting all these fireside chats with the macro environment, no surprise. Edwards was impacted in the second quarter, right, some macro challenges like contrast
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot